Patents by Inventor Vladimir Y. ELOKHOVSKIY

Vladimir Y. ELOKHOVSKIY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining glucose concentration in human blood
    Patent number: 10667728
    Abstract: Measuring the impedance of a human body region at a high frequency (ZHF) and a low frequency (ZLF). ZHF is used to obtain the value of the volume of fluid in the tissues of the region. ZLF is used to obtain the value of the volume of extracellular fluid in the tissues. The increase in the metabolic component in the volume of extracellular fluid is determined by the increase of the volume of all of the fluid in comparison with the previous measurement, determining the increase in the volume of extracellular fluid in comparison with the previous measurement and subsequently calculating the difference between the increases in the volume of all of the fluid and the volume of extracellular fluid. The glucose concentration G(tk) is determined by adding the amount of increase in the glucose concentration and the value of the glucose concentration determined at the previous measuring stage.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: June 2, 2020
    Assignee: Healbe Corporation
    Inventors: Evgeniy L. Sokolov, Andrey A. Chechik, Vladimir Y. Elokhovskiy
  • METHOD FOR DETERMINING GLUCOSE CONCENTRATION IN HUMAN BLOOD
    Publication number: 20180035930
    Abstract: Measuring the impedance of a human body region at a high frequency (ZHF) and a low frequency (ZLF). ZHF is used to obtain the value of the volume of fluid in the tissues of the region. ZLF is used to obtain the value of the volume of extracellular fluid in the tissues. The increase in the metabolic component in the volume of extracellular fluid is determined by the increase of the volume of all of the fluid in comparison with the previous measurement, determining the increase in the volume of extracellular fluid in comparison with the previous measurement and subsequently calculating the difference between the increases in the volume of all of the fluid and the volume of extracellular fluid. The glucose concentration G(tk) is determined by adding the amount of increase in the glucose concentration and the value of the glucose concentration determined at the previous measuring stage.
    Type: Application
    Filed: October 18, 2017
    Publication date: February 8, 2018
    Inventors: Evgeniy L. SOKOLOV, Andrey A. CHECHIK, Vladimir Y. ELOKHOVSKIY
  • METHOD FOR DETERMINING GLUCOSE CONCENTRATION IN HUMAN BLOOD
    Publication number: 20150073242
    Abstract: Measuring the impedance of a human body region at a high frequency (ZHF) and a low frequency (ZLF). ZHF is used to obtain the value of the volume of fluid in the tissues of the region. ZLF is used to obtain the value of the volume of extracellular fluid in the tissues. The increase in the metabolic component in the volume of extracellular fluid is determined by the increase of the volume of all of the fluid in comparison with the previous measurement, determining the increase in the volume of extracellular fluid in comparison with the previous measurement and subsequently calculating the difference between the increases in the volume of all of the fluid and the volume of extracellular fluid. The glucose concentration G(tk) is determined by adding the amount of increase in the glucose concentration and the value of the glucose concentration determined at the previous measuring stage.
    Type: Application
    Filed: August 22, 2014
    Publication date: March 12, 2015
    Inventors: Evgeniy L. SOKOLOV, Andrey A. CHECHIK, Vladimir Y. ELOKHOVSKIY